ALXN

Enter Symbol: 

Detailed Quote (ALXN)

Last Trade 86.99 Volume +1,516,238.00
Change+0.26 Shares185.62M
Change % +0.30% Market Cap.16146.74M
Today's High 87.73 52 Week High 0.00
Today's Low 86.54 52 Week Low 0.00
Bid 84.98 EPS 1
Ask88.50 P/E Ratio 86.99
Open86.79 Div. Per Share n.a
Previous Close86.73 ExchangeNasdaq
Intraday chart

Related News

May 15, 2012
Bullish Moving Average Cross by Alexion Pharmaceuticals (ALXN)

Today, shares of Alexion Pharmaceuticals (NASDAQ:ALXN) have advanced above their 10-day MA of $87.30 on a volume of 816K shares. This may provide swing traders with an opportunity for a long position, as such a...

May 15, 2012
Top 5 Companies in the Healthcare Sector with the Best Relative Performance (AMLN, MAKO, SPPI, VVUS, ALXN)

We looked at the Healthcare sector and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at today's price action of all companies in this...

May 15, 2012
Shares of Protalix BioTherapeutics Rank the Highest in Terms of Forward P/E Ratio in the Biotechnology Industry (PLX, CPHD, REGN, ALXN, LGND)

Below are the three companies in the Biotechnology industry with the highest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. Generally, the lower the...

May 14, 2012
Alexion Pharmaceuticals Earnings In Retrospect: Down 2.9% in the Last 20 Days (ALXN)

Two weeks ago on April 24th, 2012 Alexion Pharmaceuticals (NASDAQ:ALXN) reported earnings and analysts, on average, expected earnings of $0.39 on sales of $241.0 million. The company actually reported EPS of $0....

May 12, 2012
Top 5 Companies in the Biotechnology Industry With the Highest EBITDA Growth (VRTX, CPHD, ALXN, SPPI, SCLN)

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Vertex Pharmaceuticals...

May 10, 2012
Shares of Alexion Pharmaceuticals Rank the Highest in Terms of P/E Ratio in the Biotechnology Industry (ALXN, PGNX, VRTX, ACOR, IMMU)

Below are the three companies in the Biotechnology industry with the highest price to earnings (P/E) ratios. P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that investors are paying...

May 5, 2012
Top 5 Companies in the Biotechnology Industry With the Highest Projected Earnings Growth (ALXN, DUSA, ANIK, CELG, SCLN)

Below are the three companies in the Biotechnology industry with the highest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative...

May 4, 2012
Bearish Moving Average Cross by Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals (NASDAQ:ALXN) shares have crossed bearishly below their 10-day moving average of $90.51 on a volume of 348K shares. Swing traders may find an opportunity for a short position, as such a...

May 2, 2012
Alexion Pharmaceuticals Shares Up 37.9% Since SmarTrend's Buy Recommendation (ALXN)

SmarTrend identified an Uptrend for Alexion Pharmaceuticals (NASDAQ:ALXN) on October 10th, 2011 at $66.89. In approximately 7 months, Alexion Pharmaceuticals has returned 37.93% as of today's recent price of $92....

May 2, 2012
Regeneron Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Highest Future Earnings Growth (REGN, CPHD, ACOR, EBS, ALXN)

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...